These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 7567114
1. [In vitro antibacterial activity of a new fluoroquinolone, enoxacin against hospital bacteria and regression curve]. Soussy CJ, Cluzel M, Meyran M. Pathol Biol (Paris); 1995 Apr; 43(4):274-80. PubMed ID: 7567114 [Abstract] [Full Text] [Related]
9. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve]. Soussy CJ, Duval J, Chanal M, Sirot D, Bergogne-Bérézin E, Joly-Guillou ML, Malbruny B, Morel C. Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743 [Abstract] [Full Text] [Related]
10. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study. Soussy CJ, Cluzel M, Ploy MC, Kitzis MD, Morel C, Bryskier A, Courvalin P. J Antimicrob Chemother; 1999 Jun; 43 Suppl C():43-50. PubMed ID: 10404337 [Abstract] [Full Text] [Related]
11. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study]. Soussy CJ, Deforges L, Le Van Thoi J, Chanal M, Sirot D, Acar JF, Kitzis MD, Thabaut A, Meyran M, Dabernat H. Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442 [Abstract] [Full Text] [Related]
12. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin]. Aubert G, Puech C, Lucht F, Loboguerrero M, Denis M, Dorche G. Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519 [Abstract] [Full Text] [Related]
13. [Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study]. Thabaut A, Meyran M, Fabre R, Dellamonica P, Moreau N. Pathol Biol (Paris); 1994 May; 42(5):369-74. PubMed ID: 7824298 [Abstract] [Full Text] [Related]
15. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve]. Soussy CJ, Le Van Thoi J, Cluzel M, Derlot E, Kitzis MD. Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274 [Abstract] [Full Text] [Related]
16. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria]. Soussy CJ, Otterbein G, Le Van Thoi J, Thabaut A, Meyran M, Courtieu AL, Reynaud A, Dabernat H, Lareng MB, Chanal M. Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142 [Abstract] [Full Text] [Related]
17. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus]. Cetinkaya E, Coban AY, Durupinar B. Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076 [Abstract] [Full Text] [Related]
18. In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Soussy CJ, Nguyen J, Goldstein F, Dabernat H, Andremont A, Leclercq R, Drugeon H, Cavallo P, Chardon H, Etienne J, Rio Y, Courvalin P. Clin Microbiol Infect; 2003 Oct; 9(10):997-1005. PubMed ID: 14616741 [Abstract] [Full Text] [Related]